Johnson & Johnson
Search results
4 days ago · Explore Janssen’s innovative medical research & pharmaceutical product development practices to see how Janssen is creating a future where disease is a thing of the past.
Johnson & Johnson Innovative Medicine (formerly Janssen Pharmaceuticals) is a pharmaceutical company headquartered in Beerse, Belgium, and wholly-owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen .
Janssen partners directly with patients and caregivers as we develop medicines, improve clinical trials, and create educational materials and support programs. See More >
We prioritize support for activities within Janssen’s areas of scientific interest that contribute to improved knowledge, practice and performance for healthcare providers and improved health outcomes for patients.
The Janssen Pharmaceutical Companies of Johnson & Johnson | 1,027,293 followers on LinkedIn. At Janssen, we never stop working toward a future where disease is a thing of the past.
NEW BRUNSWICK, N.J., February 27, 2021– Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, to prevent COVID-19 in individuals 18 ...
Mar 3, 2021 · Learn more about the process of making a vaccine, and the ways Johnson & Johnson was able to partner and collaborate to manufacture the Janssen COVID-19 Vaccine.
3 days ago · Johnson & Johnson Innovative Medicine is leading where medicine is going. Patients inform and inspire our science-based innovations, which continue to change and save lives.
A4: JANSSEN COVID-19 VACCINE SUSPENSION FOR INJECTION is indicated for the active immunization to prevent COVID-19 caused by SARS-CoV-2 virus, in individuals 18 years of age and older.
Sep 15, 2023 · Janssen, a brand name that for six decades has been emblazoned on Johnson & Johnson’s pharmaceutical laboratories and prescription drugs, will be phased out as part of a corporate rebranding in the wake of the healthcare giant splitting in two.
